VOYA Investment Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Buy |
125,623
+52,526
| +72% | +$494K | ﹤0.01% | 1503 |
|
|
2025
Q1 | $396K | Sell |
73,097
-817
| -1% | -$4.43K | ﹤0.01% | 1971 |
|
|
2024
Q4 | $551K | Buy |
73,914
+57,205
| +342% | +$426K | ﹤0.01% | 1896 |
|
|
2024
Q3 | $134K | Sell |
16,709
-19,818
| -54% | -$158K | ﹤0.01% | 2593 |
|
|
2024
Q2 | $318K | Buy |
36,527
+2,640
| +8% | +$23K | ﹤0.01% | 2227 |
|
|
2024
Q1 | $700K | Buy |
33,887
+22,950
| +210% | +$474K | ﹤0.01% | 1830 |
|
|
2023
Q4 | $253K | Buy |
10,937
+195
| +2% | +$4.51K | ﹤0.01% | 2444 |
|
|
2023
Q3 | $85.8K | Hold |
10,742
| – | – | ﹤0.01% | 2767 |
|
|
2023
Q2 | $93.5K | Buy |
10,742
+484
| +5% | +$4.21K | ﹤0.01% | 2807 |
|
|
2023
Q1 | $30.2K | Hold |
10,258
| – | – | ﹤0.01% | 2847 |
|
|
2022
Q4 | $35.9K | Hold |
10,258
| – | – | ﹤0.01% | 2885 |
|
|
2022
Q3 | $81.1K | Hold |
10,258
| – | – | ﹤0.01% | 2825 |
|
|
2022
Q2 | $81K | Buy |
+10,258
| New | +$81K | ﹤0.01% | 2664 |
|
|
2021
Q4 | – | Sell |
-23,810
| Closed | -$248K | – | 2790 |
|
|
2021
Q3 | $248K | Buy |
23,810
+451
| +2% | +$4.7K | ﹤0.01% | 2448 |
|
|
2021
Q2 | $210K | Buy |
+23,359
| New | +$210K | ﹤0.01% | 2576 |
|
|
2020
Q2 | – | Sell |
-36,241
| Closed | -$37K | – | 2542 |
|
|
2020
Q1 | $37K | Hold |
36,241
| – | – | ﹤0.01% | 2535 |
|
|
2019
Q4 | $56K | Buy |
+36,241
| New | +$56K | ﹤0.01% | 2632 |
|